Kirsten Kliphouse

Kirsten Kliphouse has served as a director of the Company since October 12, 2022.

D. Gary Gilliland M.D., Ph.D.

D. Gary Gilliland has served as a director of the Company since April 1, 2014.

Jeffrey A. Davis

Jeffrey A. Davis has served as a director of the Company since December 1, 2019, and Chairman of the Audit Committee since June 2023.

Kerri B. Anderson

Kerrii B. Anderson has served as a director of the Company since May 17, 2006.

Ms. Anderson is the former Chief Executive Officer, President and Chief Financial Officer of Wendy’s International. Prior to joining Wendy’s in 2000, she was senior vice president and chief financial officer for 14 years for M/I Schottenstein Homes, Inc., a NYSE company that builds single-family homes. 

Sandy van der Vaart

Sandy van der Vaart has served as Executive Vice President, Chief Legal Officer and Corporate Secretary of Labcorp since February 2020.

Megan Bailey

Megan Bailey has served as Labcorp’s Executive Vice President and President, Central Laboratory Services and International since 2024. 

Previously, she served as Labcorp’s Executive Vice President and Chief Strategy and Transformation Officer where she led efforts to define Labcorp’s future growth strategy.

Mark Schroeder

Mark Schroeder has served as Labcorp’s Executive Vice President and President, Diagnostics and Chief Operations Officer since 2023. 

In this role, Mark leads all Diagnostics divisions and commercial teams, as well as routine and esoteric testing laboratory operations for Labcorp Diagnostics and global supply chain.

Lance Berberian

In October 2024, Lance Berberian announced his planned retirement from Labcorp in 2025. Lance served as Executive Vice President and Chief Information and Technology Officer from 2014 through October 2024. In November 2024, he stepped into the role of Special Advisor, Strategy. In this role he is working directly with the CEO and the executive team to drive the development and implementation of Labcorp’s enterprise strategy.

Glenn Eisenberg

Glenn Eisenberg has served as Executive Vice President and Chief Financial Officer of Labcorp since 2014.

Brian Caveney, M.D., J.D., M.P.H.

EVP and President, Early Development Research Laboratories

Brian Caveney, M.D. has served as Executive Vice President and President, Early Development Research Laboratories and Chief Medical and Scientific Officer at Labcorp since 2023.

In his current role, Brian leads all early development research laboratories globally and oversees all medical and scientific affairs, oncology, cell and gene therapy, and quality for Labcorp.